To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
Arsenal Capital-backed CellCarta buys Reveal Biosciences
Montreal-based CellCarta, formerly Caprion-HistoGeneX, has acquired Reveal Biosciences, a San Diego, California-based computational pathology company.
